Share Price and Basic Stock Data
Last Updated: December 12, 2025, 7:30 pm
| PEG Ratio | -13.12 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bhagiradha Chemicals & Industries Ltd operates in the agrochemicals and pesticides sector, which is crucial for India’s agricultural productivity. As of the latest reporting period, the company’s stock price stood at ₹232, with a market capitalization of ₹3,007 Cr. Over the years, Bhagiradha has shown a fluctuating sales trajectory, recording revenues of ₹502 Cr in FY 2023, which dipped to ₹407 Cr in FY 2024, before rebounding to ₹436 Cr in FY 2025. This inconsistency raises questions about demand stability and market positioning. The trailing twelve months (TTM) sales figure is ₹449 Cr, hinting at a potential recovery phase. The reported sales figures from the last few quarters reveal a trend where sales peaked at ₹131.81 Cr in September 2022 but saw a notable drop to ₹100.01 Cr in June 2023, raising concerns about seasonal impacts or competitive pressures affecting market share.
Profitability and Efficiency Metrics
Profitability metrics for Bhagiradha reveal a mixed picture. The operating profit margin (OPM) declined to 8.08% in FY 2025 from a healthier 16% in FY 2023, indicating rising costs or pricing pressures that may be squeezing margins. The company reported a net profit of ₹28 Cr for FY 2025, which is a decline from previous highs, reflecting the challenges in maintaining profitability amidst fluctuating sales. The return on equity (ROE) is notably low at 4.91%, suggesting that shareholders are not seeing robust returns relative to their investments. Additionally, the company’s interest coverage ratio stands at a comfortable 6.50x, indicating that it can easily meet its interest obligations, which is a positive sign amidst these profitability concerns. However, the declining net profit and margins may signal operational inefficiencies that need urgent attention.
Balance Sheet Strength and Financial Ratios
Examining the balance sheet, Bhagiradha Chemicals appears to have a reasonable level of financial stability. The company’s total borrowings amounted to ₹93 Cr, which is modest compared to its reserves of ₹699 Cr. This implies a strong buffer against financial distress, with a debt-to-equity ratio of just 0.12x, reflecting prudent financial management. However, the price-to-book value ratio at 5.28x seems stretched, indicating that the market may be pricing in growth expectations that could be difficult to meet. The cash conversion cycle has lengthened to 169 days, suggesting inefficiencies in managing working capital, particularly in inventory and receivables. This extended cycle could strain liquidity if not addressed, potentially resulting in cash flow issues that could hinder operational flexibility.
Shareholding Pattern and Investor Confidence
Investor confidence in Bhagiradha Chemicals appears somewhat mixed, as reflected in its shareholding pattern. Promoter holdings have declined to 19.60%, which could signal a lack of confidence from the founding members or a strategic shift. On the other hand, public shareholding remains robust at 77.48%, indicating strong retail interest. Foreign institutional investors (FIIs) have a negligible presence at 0.05%, which raises questions about international confidence in the company’s prospects. Domestic institutional investors (DIIs) hold a modest 2.89%, reflecting cautious optimism. The total number of shareholders has shown significant growth, jumping from 3,465 in December 2022 to 13,761 by September 2025, suggesting that the company is attracting retail investors, possibly due to low entry prices in a volatile market.
Outlook, Risks, and Final Insight
The outlook for Bhagiradha Chemicals is clouded by both opportunities and risks. On the one hand, the agrochemicals sector is poised for growth due to increasing agricultural demands, which could benefit companies like Bhagiradha. However, the declining profitability metrics and increasing operational inefficiencies pose significant risks. Investors should be cautious about the company’s ability to stabilize its sales and improve margins in a competitive market. Additionally, the high price-to-book ratio suggests that the stock might be overvalued relative to its assets, which could lead to corrections if performance does not improve. Overall, while the fundamentals show potential for recovery, the risks surrounding profitability and operational efficiency warrant a close watch, making this a stock for those who can tolerate short-term volatility in pursuit of long-term gains.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,097 Cr. | 1,412 | 2,142/1,398 | 15.2 | 487 | 0.42 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 801 Cr. | 238 | 391/165 | 16.5 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 65.1 Cr. | 125 | 149/56.6 | 11.7 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,969 Cr. | 229 | 344/224 | 112 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 861 Cr. | 364 | 670/244 | 67.2 | 342 | 0.82 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,008.95 Cr | 1,148.94 | 32.09 | 382.34 | 0.44% | 15.21% | 19.87% | 7.04 |
All Competitor Stocks of Bhagiradha Chemicals & Industries Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121.72 | 131.81 | 126.00 | 122.57 | 100.01 | 122.01 | 74.37 | 110.32 | 110.78 | 100.22 | 102.73 | 122.63 | 123.78 |
| Expenses | 102.10 | 111.47 | 106.39 | 104.28 | 92.80 | 108.45 | 66.19 | 96.37 | 98.94 | 90.47 | 93.43 | 115.39 | 113.78 |
| Operating Profit | 19.62 | 20.34 | 19.61 | 18.29 | 7.21 | 13.56 | 8.18 | 13.95 | 11.84 | 9.75 | 9.30 | 7.24 | 10.00 |
| OPM % | 16.12% | 15.43% | 15.56% | 14.92% | 7.21% | 11.11% | 11.00% | 12.65% | 10.69% | 9.73% | 9.05% | 5.90% | 8.08% |
| Other Income | 0.20 | 0.51 | 0.62 | 0.51 | 0.42 | 0.48 | 1.38 | 2.53 | 3.64 | 5.24 | 5.50 | 6.10 | 3.50 |
| Interest | 1.77 | 0.82 | 0.84 | 1.55 | 1.72 | 2.26 | 1.57 | 2.14 | 1.34 | 1.65 | 2.29 | 1.36 | 2.93 |
| Depreciation | 2.30 | 2.40 | 2.45 | 2.51 | 2.61 | 2.70 | 2.82 | 2.83 | 2.82 | 2.91 | 3.11 | 3.10 | 3.36 |
| Profit before tax | 15.75 | 17.63 | 16.94 | 14.74 | 3.30 | 9.08 | 5.17 | 11.51 | 11.32 | 10.43 | 9.40 | 8.88 | 7.21 |
| Tax % | 23.94% | 28.93% | 28.57% | 33.38% | 33.33% | 30.62% | 28.63% | 29.37% | 36.13% | 24.45% | 24.15% | 41.89% | -14.84% |
| Net Profit | 11.98 | 12.52 | 12.09 | 9.82 | 2.20 | 6.29 | 3.69 | 8.12 | 7.23 | 7.87 | 7.13 | 5.16 | 8.29 |
| EPS in Rs | 1.15 | 1.20 | 1.16 | 0.94 | 0.21 | 0.60 | 0.35 | 0.78 | 0.58 | 0.63 | 0.57 | 0.40 | 0.64 |
Last Updated: August 19, 2025, 10:20 pm
Below is a detailed analysis of the quarterly data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 123.78 Cr.. The value appears strong and on an upward trend. It has increased from 122.63 Cr. (Mar 2025) to 123.78 Cr., marking an increase of 1.15 Cr..
- For Expenses, as of Jun 2025, the value is 113.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 115.39 Cr. (Mar 2025) to 113.78 Cr., marking a decrease of 1.61 Cr..
- For Operating Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.24 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.76 Cr..
- For OPM %, as of Jun 2025, the value is 8.08%. The value appears strong and on an upward trend. It has increased from 5.90% (Mar 2025) to 8.08%, marking an increase of 2.18%.
- For Other Income, as of Jun 2025, the value is 3.50 Cr.. The value appears to be declining and may need further review. It has decreased from 6.10 Cr. (Mar 2025) to 3.50 Cr., marking a decrease of 2.60 Cr..
- For Interest, as of Jun 2025, the value is 2.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.36 Cr. (Mar 2025) to 2.93 Cr., marking an increase of 1.57 Cr..
- For Depreciation, as of Jun 2025, the value is 3.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.36 Cr., marking an increase of 0.26 Cr..
- For Profit before tax, as of Jun 2025, the value is 7.21 Cr.. The value appears to be declining and may need further review. It has decreased from 8.88 Cr. (Mar 2025) to 7.21 Cr., marking a decrease of 1.67 Cr..
- For Tax %, as of Jun 2025, the value is -14.84%. The value appears to be improving (decreasing) as expected. It has decreased from 41.89% (Mar 2025) to -14.84%, marking a decrease of 56.73%.
- For Net Profit, as of Jun 2025, the value is 8.29 Cr.. The value appears strong and on an upward trend. It has increased from 5.16 Cr. (Mar 2025) to 8.29 Cr., marking an increase of 3.13 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.64. The value appears strong and on an upward trend. It has increased from 0.40 (Mar 2025) to 0.64, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:47 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 220 | 152 | 203 | 183 | 384 | 246 | 318 | 436 | 502 | 407 | 436 | 449 |
| Expenses | 164 | 209 | 148 | 191 | 172 | 343 | 229 | 271 | 367 | 424 | 364 | 398 | 413 |
| Operating Profit | 11 | 11 | 4 | 11 | 12 | 41 | 17 | 47 | 68 | 78 | 43 | 38 | 36 |
| OPM % | 6% | 5% | 3% | 6% | 6% | 11% | 7% | 15% | 16% | 16% | 11% | 9% | 8% |
| Other Income | 1 | 1 | 1 | 2 | -8 | 1 | 4 | 2 | 1 | 2 | 5 | 20 | 20 |
| Interest | 4 | 6 | 7 | 7 | 7 | 8 | 5 | 8 | 9 | 5 | 8 | 7 | 8 |
| Depreciation | 5 | 3 | 4 | 4 | 3 | 5 | 7 | 8 | 9 | 10 | 11 | 12 | 12 |
| Profit before tax | 2 | 3 | -5 | 3 | -6 | 29 | 9 | 32 | 51 | 65 | 29 | 40 | 36 |
| Tax % | 10% | 17% | -39% | 61% | -77% | 37% | 27% | 27% | 30% | 29% | 30% | 32% | |
| Net Profit | 2 | 3 | -3 | 1 | -1 | 18 | 7 | 23 | 36 | 46 | 20 | 27 | 28 |
| EPS in Rs | 0.31 | 0.40 | -0.51 | 0.16 | -0.14 | 1.78 | 0.63 | 2.28 | 3.50 | 4.46 | 1.95 | 2.11 | 2.24 |
| Dividend Payout % | 26% | 20% | 0% | 0% | 0% | 9% | 0% | 0% | 7% | 9% | 5% | 7% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 50.00% | -200.00% | 133.33% | -200.00% | 1900.00% | -61.11% | 228.57% | 56.52% | 27.78% | -56.52% | 35.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -250.00% | 333.33% | -333.33% | 2100.00% | -1961.11% | 289.68% | -172.05% | -28.74% | -84.30% | 91.52% |
Bhagiradha Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 12% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 40% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 56% |
| 3 Years: | 27% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:31 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 8 | 8 | 8 | 8 | 8 | 10 | 10 | 13 | 13 |
| Reserves | 43 | 44 | 41 | 46 | 94 | 120 | 124 | 148 | 182 | 304 | 407 | 686 | 699 |
| Borrowings | 53 | 71 | 62 | 64 | 61 | 47 | 43 | 62 | 81 | 50 | 61 | 77 | 93 |
| Other Liabilities | 41 | 75 | 71 | 91 | 80 | 98 | 50 | 55 | 71 | 82 | 89 | 138 | 127 |
| Total Liabilities | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 | 932 |
| Fixed Assets | 48 | 52 | 66 | 69 | 77 | 106 | 138 | 145 | 149 | 164 | 176 | 203 | 215 |
| CWIP | 9 | 16 | 0 | 0 | 0 | 4 | 4 | 1 | 3 | 6 | 5 | 15 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 9 | 42 | 80 | 42 | 410 |
| Other Assets | 85 | 127 | 113 | 138 | 166 | 164 | 83 | 119 | 181 | 234 | 306 | 654 | 305 |
| Total Assets | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 | 932 |
Below is a detailed analysis of the balance sheet data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 699.00 Cr.. The value appears strong and on an upward trend. It has increased from 686.00 Cr. (Mar 2025) to 699.00 Cr., marking an increase of 13.00 Cr..
- For Borrowings, as of Sep 2025, the value is 93.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 77.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 127.00 Cr.. The value appears to be improving (decreasing). It has decreased from 138.00 Cr. (Mar 2025) to 127.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 932.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 914.00 Cr. (Mar 2025) to 932.00 Cr., marking an increase of 18.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 215.00 Cr.. The value appears strong and on an upward trend. It has increased from 203.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 410.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2025) to 410.00 Cr., marking an increase of 368.00 Cr..
- For Other Assets, as of Sep 2025, the value is 305.00 Cr.. The value appears to be declining and may need further review. It has decreased from 654.00 Cr. (Mar 2025) to 305.00 Cr., marking a decrease of 349.00 Cr..
- For Total Assets, as of Sep 2025, the value is 932.00 Cr.. The value appears strong and on an upward trend. It has increased from 914.00 Cr. (Mar 2025) to 932.00 Cr., marking an increase of 18.00 Cr..
Notably, the Reserves (699.00 Cr.) exceed the Borrowings (93.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -60.00 | -58.00 | -53.00 | -49.00 | -6.00 | -26.00 | -15.00 | -13.00 | 28.00 | -18.00 | -39.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 82 | 67 | 31 | 71 | 80 | 17 | 68 | 81 | 94 | 95 | 145 |
| Inventory Days | 99 | 139 | 256 | 282 | 281 | 77 | 137 | 97 | 91 | 108 | 166 | 158 |
| Days Payable | 104 | 143 | 216 | 205 | 191 | 110 | 59 | 89 | 73 | 69 | 95 | 135 |
| Cash Conversion Cycle | 66 | 78 | 106 | 108 | 161 | 47 | 95 | 76 | 99 | 132 | 167 | 169 |
| Working Capital Days | 4 | -0 | -19 | -21 | 49 | 16 | -12 | 21 | 32 | 91 | 120 | 395 |
| ROCE % | 7% | 8% | 0% | 8% | 7% | 22% | 7% | 20% | 25% | 22% | 9% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.14 | 17.51 | 44.35 | 43.02 | 28.06 |
| Diluted EPS (Rs.) | 1.14 | 16.10 | 44.35 | 43.02 | 28.06 |
| Cash EPS (Rs.) | 2.14 | 28.06 | 52.82 | 53.37 | 37.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Revenue From Operations / Share (Rs.) | 33.97 | 391.76 | 482.52 | 522.74 | 381.44 |
| PBDIT / Share (Rs.) | 3.56 | 43.81 | 75.52 | 82.94 | 57.02 |
| PBIT / Share (Rs.) | 2.50 | 33.26 | 66.10 | 72.47 | 47.22 |
| PBT / Share (Rs.) | 1.95 | 25.87 | 61.30 | 61.56 | 38.57 |
| Net Profit / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| NP After MI And SOA / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| PBDIT Margin (%) | 10.49 | 11.18 | 15.65 | 15.86 | 14.94 |
| PBIT Margin (%) | 7.34 | 8.49 | 13.69 | 13.86 | 12.38 |
| PBT Margin (%) | 5.73 | 6.60 | 12.70 | 11.77 | 10.11 |
| Net Profit Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| NP After MI And SOA Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| Return on Networth / Equity (%) | 2.03 | 4.40 | 14.41 | 18.82 | 14.97 |
| Return on Capital Employeed (%) | 4.38 | 7.68 | 19.86 | 28.84 | 22.10 |
| Return On Assets (%) | 1.48 | 3.16 | 10.10 | 10.45 | 8.53 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 | 0.05 | 0.05 | 0.12 |
| Total Debt / Equity (X) | 0.12 | 0.14 | 0.15 | 0.42 | 0.37 |
| Asset Turnover Ratio (%) | 0.58 | 0.79 | 1.27 | 1.42 | 1.28 |
| Current Ratio (X) | 1.92 | 2.23 | 2.27 | 1.31 | 1.20 |
| Quick Ratio (X) | 1.26 | 1.34 | 1.36 | 0.79 | 0.66 |
| Inventory Turnover Ratio (X) | 3.65 | 2.69 | 4.23 | 4.66 | 3.68 |
| Dividend Payout Ratio (NP) (%) | 8.97 | 17.13 | 6.91 | 2.32 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 4.48 | 10.68 | 5.67 | 1.86 | 0.00 |
| Earning Retention Ratio (%) | 91.03 | 82.87 | 93.09 | 97.68 | 0.00 |
| Cash Earning Retention Ratio (%) | 95.52 | 89.32 | 94.33 | 98.14 | 0.00 |
| Interest Coverage Ratio (X) | 6.50 | 5.93 | 15.74 | 7.61 | 5.75 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 3.37 | 10.04 | 4.93 | 3.69 |
| Enterprise Value (Cr.) | 3659.46 | 1726.83 | 1291.27 | 923.65 | 478.11 |
| EV / Net Operating Revenue (X) | 8.31 | 4.24 | 2.57 | 2.12 | 1.50 |
| EV / EBITDA (X) | 79.16 | 37.88 | 16.43 | 13.36 | 10.06 |
| MarketCap / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| Retention Ratios (%) | 91.02 | 82.86 | 93.08 | 97.67 | 0.00 |
| Price / BV (X) | 5.28 | 4.05 | 3.98 | 4.46 | 2.70 |
| Price / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| EarningsYield | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 |
After reviewing the key financial ratios for Bhagiradha Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 17.51 (Mar 24) to 1.14, marking a decrease of 16.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 16.10 (Mar 24) to 1.14, marking a decrease of 14.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has decreased from 28.06 (Mar 24) to 2.14, marking a decrease of 25.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.97. It has decreased from 391.76 (Mar 24) to 33.97, marking a decrease of 357.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.56. This value is within the healthy range. It has decreased from 43.81 (Mar 24) to 3.56, marking a decrease of 40.25.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.50. This value is within the healthy range. It has decreased from 33.26 (Mar 24) to 2.50, marking a decrease of 30.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 25.87 (Mar 24) to 1.95, marking a decrease of 23.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For PBDIT Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.49, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 7.34. This value is below the healthy minimum of 10. It has decreased from 8.49 (Mar 24) to 7.34, marking a decrease of 1.15.
- For PBT Margin (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 10. It has decreased from 6.60 (Mar 24) to 5.73, marking a decrease of 0.87.
- For Net Profit Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 5. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 8. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 15. It has decreased from 4.40 (Mar 24) to 2.03, marking a decrease of 2.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 4.38, marking a decrease of 3.30.
- For Return On Assets (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 3.16 (Mar 24) to 1.48, marking a decrease of 1.68.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.12, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.58. It has decreased from 0.79 (Mar 24) to 0.58, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.65, marking an increase of 0.96.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 20. It has decreased from 17.13 (Mar 24) to 8.97, marking a decrease of 8.16.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 20. It has decreased from 10.68 (Mar 24) to 4.48, marking a decrease of 6.20.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.03. This value exceeds the healthy maximum of 70. It has increased from 82.87 (Mar 24) to 91.03, marking an increase of 8.16.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.52. This value exceeds the healthy maximum of 70. It has increased from 89.32 (Mar 24) to 95.52, marking an increase of 6.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 6.50, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 24) to 2.95, marking a decrease of 0.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,659.46. It has increased from 1,726.83 (Mar 24) to 3,659.46, marking an increase of 1,932.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 4.24 (Mar 24) to 8.31, marking an increase of 4.07.
- For EV / EBITDA (X), as of Mar 25, the value is 79.16. This value exceeds the healthy maximum of 15. It has increased from 37.88 (Mar 24) to 79.16, marking an increase of 41.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For Retention Ratios (%), as of Mar 25, the value is 91.02. This value exceeds the healthy maximum of 70. It has increased from 82.86 (Mar 24) to 91.02, marking an increase of 8.16.
- For Price / BV (X), as of Mar 25, the value is 5.28. This value exceeds the healthy maximum of 3. It has increased from 4.05 (Mar 24) to 5.28, marking an increase of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhagiradha Chemicals & Industries Ltd:
- Net Profit Margin: 3.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.38% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.03% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 112 (Industry average Stock P/E: 25.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.12
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Unit No.1011A, Level 1, Sky One (Wing A), Hyderabad Telangana 500032 | info@bhagirad.com http://www.bhagirad.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Chandra Sekhar Singavarapu | Managing Director |
| Mr. Arvind Kumar Anegondi | Executive Director & CEO |
| Mr. Krishna Rao S V Gadepalli | Ind. Non-Executive Director |
| Dr. G Aruna | Ind. Non-Executive Woman Director |
| Mr. Suresh Kumar Somani | Non Exe.Non Ind.Director |
| Mrs. Lalitha Sree Singavarapu | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd's intrinsic value (as of 12 December 2025) is 241.69 which is 5.54% higher the current market price of 229.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,969 Cr. market cap, FY2025-2026 high/low of 344/224, reserves of ₹699 Cr, and liabilities of 932 Cr.
What is the Market Cap of Bhagiradha Chemicals & Industries Ltd?
The Market Cap of Bhagiradha Chemicals & Industries Ltd is 2,969 Cr..
What is the current Stock Price of Bhagiradha Chemicals & Industries Ltd as on 12 December 2025?
The current stock price of Bhagiradha Chemicals & Industries Ltd as on 12 December 2025 is 229.
What is the High / Low of Bhagiradha Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bhagiradha Chemicals & Industries Ltd stocks is 344/224.
What is the Stock P/E of Bhagiradha Chemicals & Industries Ltd?
The Stock P/E of Bhagiradha Chemicals & Industries Ltd is 112.
What is the Book Value of Bhagiradha Chemicals & Industries Ltd?
The Book Value of Bhagiradha Chemicals & Industries Ltd is 54.9.
What is the Dividend Yield of Bhagiradha Chemicals & Industries Ltd?
The Dividend Yield of Bhagiradha Chemicals & Industries Ltd is 0.07 %.
What is the ROCE of Bhagiradha Chemicals & Industries Ltd?
The ROCE of Bhagiradha Chemicals & Industries Ltd is 7.44 %.
What is the ROE of Bhagiradha Chemicals & Industries Ltd?
The ROE of Bhagiradha Chemicals & Industries Ltd is 4.91 %.
What is the Face Value of Bhagiradha Chemicals & Industries Ltd?
The Face Value of Bhagiradha Chemicals & Industries Ltd is 1.00.